NLS Pharmaceutics's total assets for Q2 2025 were $4.34M, an increase of 94.24% from the previous quarter. NLSP total liabilities were $1.46M for the fiscal quarter, a 76.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.